Collateral damage: has the COVID-19 pandemic more strongly impacted medical research than other scientific areas

The principle of resource allocation states that diversion of resources to attend a function may compromise others. The COVID-19 pandemic required a rapid response with a justifiable relocation of equipment, funds and human resources. Based on the ecological principle of allocation, we tested whethe...

Descripción completa

Detalles Bibliográficos
Autores: Farji Brener, Alejandro, Amador Vargas, Sabrina
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2023
País:Argentina
Institución:Universidad Nacional del Comahue
Repositorio:Repositorio Digital Institucional (UNCo)
Idioma:inglés
OAI Identifier:oai:rdi.uncoma.edu.ar:uncomaid/17290
Acceso en línea:http://rdi.uncoma.edu.ar/handle/uncomaid/17290
Access Level:acceso abierto
Palabra clave:COVID-19
Pandemic
Pandemia
Collateral damage
Daños colaterales
Public health
Salud pública
Funding
Financiamiento
Ciencias Biomédicas
Descripción
Sumario:The principle of resource allocation states that diversion of resources to attend a function may compromise others. The COVID-19 pandemic required a rapid response with a justifiable relocation of equipment, funds and human resources. Based on the ecological principle of allocation, we tested whether the relocation of resources to support COVID-19 research was more detrimental to medical research than to research in other scientific areas. We compared the yearly number of published articles from 2015 to 2021 using disease-related keywords and non-medical scientific keywords. Contrary to the expectation, we found an abrupt reduction in the publication rates in all research areas from 2019 to 2020 or 2021, compared to the pre-pandemic period (2015–2019). The allocation effect on medical research may be overshadowed by stronger effects of the pandemic, or it may become evident in the coming years. The drastic reduction in published papers could have negative consequences for scientific advancements, including understanding and curing diseases other than COVID-19 that strongly affect humanity.